Century Therapeutics, Inc. (IPSC)
1.47
+0.01
(+0.68%)
USD |
NASDAQ |
Oct 09, 16:00
1.47
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Cash from Operations (Quarterly) : -19.83M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.83M |
| March 31, 2026 | -25.24M |
| December 31, 2025 | -16.08M |
| September 30, 2025 | -25.58M |
| June 30, 2025 | -27.59M |
| March 31, 2025 | -34.62M |
| December 31, 2024 | -24.22M |
| September 30, 2024 | -28.33M |
| June 30, 2024 | -27.33M |
| March 31, 2024 | -30.25M |
| December 31, 2023 | -26.23M |
| September 30, 2023 | -13.65M |
| June 30, 2023 | -19.25M |
| Date | Value |
|---|---|
| March 31, 2023 | -29.44M |
| December 31, 2022 | -23.03M |
| September 30, 2022 | -24.36M |
| June 30, 2022 | -25.68M |
| March 31, 2022 | 86.63M |
| December 31, 2021 | -24.48M |
| September 30, 2021 | -24.11M |
| June 30, 2021 | -19.02M |
| March 31, 2021 | -22.18M |
| December 31, 2020 | -14.73M |
| September 30, 2020 | -9.225M |
| June 30, 2020 | -10.43M |
| March 31, 2020 | -6.884M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -14.15M |
| Exicure, Inc. | -0.887M |
| Absci Corp. | -27.56M |
| Celularity, Inc. | 1.447M |
| Cardio Diagnostics Holdings, Inc. | -1.342M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 17.77M |
| Cash from Financing (Quarterly) | 0.311M |
| Free Cash Flow | -88.07M |
| Free Cash Flow Per Share (Quarterly) | -0.0998 |
| Free Cash Flow to Equity (Quarterly) | -11.17M |
| Free Cash Flow to Firm (Quarterly) | -20.53M |
| Free Cash Flow Yield | -41.81% |